Progressive Familial Intrahepatic Cholestasis Treatment Market Projected to Reach $156.14 million by 2030 – Exclusive Report by 360iResearch

Posted on by

PUNE, India, April 18, 2024 /PRNewswire/ — The report titled “Progressive Familial Intrahepatic Cholestasis Treatment Market by Drug Type (Cholestyramine, Rifampicin, Ursodeoxycholic Acid), Distribution Channel (Hospital Pharmacies, Online Pharmacies, Retail Pharmacies), End-Users -…

Posted in UncategorizedTagged
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.